论文部分内容阅读
西班牙消息:肺癌患者的血清铜/锌(Cu/Za)比明显高于良性肺病患者及正常对照组。如治疗前肺癌患者血清Cu/Zn比为2.25以上,肿瘤不能切除的可能性很大,能存活24个月者不超过5％。肺癌患者的平均血清锌值(62.7ug/dl)较健康者(73.3ug/dl)及良性肺病患者(69.9ug/dl)明显下降。TNM分类的肺癌患者,血清锌浓度在第Ⅲ期平均为60ug/dl,Ⅱ期和Ⅰ期平均为66.7ug/dl。肺癌患者的平均血铜值(140.1ug/dl)较健康暂(100.0ug/dl)及良性肺病患者(112.5ug/dl)明显升高。Ⅲ期患者血清铜平均值为150.3ug/dl,而Ⅰ期和Ⅱ期患者则为125.0ug/dl。
Spain News: The serum copper/zinc (Cu/Za) ratio of lung cancer patients is significantly higher than that of patients with benign lung disease and normal controls. If the ratio of serum Cu/Zn in patients with lung cancer before treatment is 2.25 or more, there is a high possibility that the tumor cannot be removed, and no more than 5% of the patients survive for 24 months. The average serum zinc level (62.7ug/dl) of lung cancer patients was significantly lower than that of healthy individuals (73.3ug/dl) and benign lung diseases (69.9ug/dl). TNM classification of lung cancer patients, serum zinc concentration in the third phase of an average of 60ug/dl, phase II and I average of 66.7ug/dl. The average blood copper level of patients with lung cancer (140.1ug/dl) was significantly higher than that of the healthy temporary (100.0ug/dl) and benign lung disease patients (112.5ug/dl). The mean serum copper level for stage III patients was 150.3 ug/dl, compared with 125.0 ug/dl for stage I and stage II patients.